missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human B4GALT7 (aa 81-201) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (97%), Rat (97%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-59949 (PA5-59949. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Required for the biosynthesis of the tetrasaccharide linkage region of proteoglycans, especially for small proteoglycans in skin fibroblasts.
Specifications
Specifications
| Accession Number | Q9UBV7 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 11285 |
| Name | Human B4GALT7 (aa 81-201) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | B4galt7; b4Gal-T7; Beta-1,4-galactosyltransferase 7; beta-1,4-galactosyltransferase VII; beta-1,4-GalTase 7; beta4Gal-T7; beta4GalT-VII; EDSP1; EDSSLA; galactosyltransferase I; proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7; UDP-galactose:beta-xylose beta-1,4-galactosyltransferase; UNQ748/PRO1478; XGALT1; XGalT-1; XGPT; XGPT1; Xylosylprotein 4-beta-galactosyltransferase; xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7; Xylosylprotein beta-1,4-galactosyltransferase; xylosylprotein beta1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) |
| Common Name | B4GALT7 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction